Evaluation of

Adjuvant Helicobacter pylori IFN-γ IL-4 OipA Propolis Vaccine

Journal

Iranian journal of basic medical sciences
ISSN: 2008-3866
Titre abrégé: Iran J Basic Med Sci
Pays: Iran
ID NLM: 101517966

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 14 03 2021
accepted: 12 07 2021
entrez: 27 1 2022
pubmed: 28 1 2022
medline: 28 1 2022
Statut: ppublish

Résumé

Outer inflammatory protein A (OipA) is an essential adhesin of C57BL/6 mice were divided into nine groups according to the disposition of antigen and adjuvant and route of administration: subcutaneous (sc) or gavage. The administrated recombinant purified OipA and propolis concentrations were 10 μg/ml and 40 μg/ml, respectively. After vaccination, we measured expression levels of IFN-γ and IL-4 cytokine genes in the spleen cells of mice by real-time PCR. All results were contrasted with the negative sample. By sc injection, the expression of INF-γ was increased 3.5 and 2.9-fold for OipA and OipA plus propolis, respectively. By gavage 4.4 and 11-fold increase was found for OipA and OipA plus propolis, respectively. The administration of propolis by gavage showed more increase than Sc injection concerning the production of INF-γ. The 11-fold increase for injection of OipA plus propolis by gavage was comparable OipA plus Freund's adjuvant injected subcutaneously. This result suggested an excellent immunological response toward OipA concerning the production of INF-γ in mice. In all cases there were no notable IL-4 production increases. The results confirm the efficiency of OipA in induction of IFN-γ production, and thereby the cellular immune response. Propolis could be a suitable adjuvant.

Identifiants

pubmed: 35083009
doi: 10.22038/ijbms.2021.56232.12579
pmc: PMC8751746
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1220-1230

Déclaration de conflit d'intérêts

The results presented in this paper were part of a student thesis. The authors have no financial or commercial conflicts of interest with the current work or its publication.

Références

Mol Cells. 2003 Aug 31;16(1):106-12
pubmed: 14503853
Immunobiology. 2011 Jul;216(7):803-10
pubmed: 21269729
Biomed Res Int. 2019 Dec 12;2019:4836378
pubmed: 31915694
J Immunol. 2004 Sep 1;173(5):3348-56
pubmed: 15322198
Gut. 2006 Sep;55(9):1360-1; author reply 1361
pubmed: 16905702
Helicobacter. 2007 Apr;12(2):89-102
pubmed: 17309745
Mucosal Immunol. 2018 Jul;11(4):1254-1264
pubmed: 29467446
Gut Pathog. 2016 Nov 21;8:61
pubmed: 27895717
Vaccine. 2012 Jun 6;30(26):3876-84
pubmed: 22512976
Vet Parasitol. 2007 Mar 31;144(3-4):279-86
pubmed: 17113712
J Pharmacol Pharmacother. 2013 Oct;4(4):303-6
pubmed: 24250214
Gut Liver. 2009 Jun;3(2):81-7
pubmed: 20431728
Biomed Res. 2019;40(2):87-95
pubmed: 30982804
Infect Immun. 2010 Oct;78(10):4251-60
pubmed: 20696831
Cell Microbiol. 2008 Apr;10(4):1008-20
pubmed: 18067607
Clin Diagn Lab Immunol. 2000 Sep;7(5):769-73
pubmed: 10973452
J Immunol Res. 2018 Mar 7;2018:9830701
pubmed: 29707588
Mem Inst Oswaldo Cruz. 2010 Nov;105(7):908-13
pubmed: 21120362
J Immunol. 2009 Jun 1;182(11):7085-101
pubmed: 19454706
Galen Med J. 2020 Dec 08;9:e1687
pubmed: 34466568
Z Naturforsch C J Biosci. 2003 Jul-Aug;58(7-8):580-9
pubmed: 12939048
Asian Pac J Trop Med. 2017 Mar;10(3):253-262
pubmed: 28442108
Infect Immun. 2001 Nov;69(11):6597-603
pubmed: 11598027
Clin Microbiol Rev. 2010 Oct;23(4):713-39
pubmed: 20930071
Annu Rev Immunol. 2001;19:523-63
pubmed: 11244046
Appl Microbiol Biotechnol. 2019 Apr;103(8):3407-3420
pubmed: 30810777
Analyst. 2014 May 21;139(10):2507-14
pubmed: 24665464
Helicobacter. 2011 Sep;16 Suppl 1:26-32
pubmed: 21896082
Vaccine. 2012 Dec 17;31(1):120-6
pubmed: 23137845
Saudi J Gastroenterol. 2016 Mar-Apr;22(2):161-8
pubmed: 26997224
Clin Microbiol Rev. 2006 Oct;19(4):597-613
pubmed: 17041136
J Ethnopharmacol. 2004 Mar;91(1):25-30
pubmed: 15036463
J Ethnopharmacol. 2003 Jul;87(1):93-7
pubmed: 12787960
Gastroenterology. 2002 Aug;123(2):414-24
pubmed: 12145793
J Ethnopharmacol. 2007 Aug 15;113(1):1-14
pubmed: 17580109
Vaccine. 2019 May 27;37(24):3167-3178
pubmed: 31047671
Trop Med Infect Dis. 2021 Apr 28;6(2):
pubmed: 33925118
Food Chem Toxicol. 1998 Apr;36(4):347-63
pubmed: 9651052
Vaccine. 2012 Aug 3;30(36):5310-5
pubmed: 22749593
PLoS One. 2019 Jun 18;14(6):e0218033
pubmed: 31211792
Clin Chim Acta. 2003 Dec;338(1-2):11-6
pubmed: 14637260
Turk J Med Sci. 2016 Feb 27;47(1):326-333
pubmed: 28263510
Vaccine. 2014 Oct 21;32(46):6054-60
pubmed: 25236588
Pediatrics. 2006 May;117(5):e878-86
pubmed: 16618789

Auteurs

Hengameh Soudi (H)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Tahereh Falsafi (T)

Microbiology department, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.

Mohaddeseh Mahboubi (M)

Medicinal Plants Research Department, Research and Development, TabibDaru Pharmaceutical Company, Kashan, Iran.

Sara Gharavi (S)

Biotechnology Department, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.

Classifications MeSH